buserelin has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar-Rojas, A; Arechavaleta-Velásco, F; Conn, PM; Huerta-Reyes, M; Maya-Núñez, G; Ulloa-Aguirre, A; Valdés, J | 1 |
1 other study(ies) available for buserelin and Invasiveness, Neoplasm
Article | Year |
---|---|
Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Topics: Actins; Breast Neoplasms; Buserelin; Cell Line, Tumor; Cell Movement; Enzyme Activation; Female; Flow Cytometry; Fluorometry; Focal Adhesions; Gonadotropin-Releasing Hormone; Humans; Immunoblotting; MCF-7 Cells; Microscopy, Confocal; Mutation; Neoplasm Invasiveness; Polymerization; Receptors, LHRH; rhoA GTP-Binding Protein; Stress Fibers; Transfection | 2012 |